Publications by authors named "Michael B Fowler"

Claim this Profile
G
Generation and characterization of induced pluripotent stem cells from breast cancer patients carrying ATM mutations.
Mao Zhang, Ravichandra Venkateshappa, Audrey Li, Michael B Fowler, Melinda L Telli

Stem Cell Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Changing Landscape of Mortality for Systemic Light Chain Amyloidosis.
Christopher D Barrett, Katharine Dobos, Michaela Liedtke, Mirela Tuzovic, Francois Haddad, Michael B Fowler

JACC Heart Fail· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dipeptidyl peptidase 4 inhibition increases myocardial glucose uptake in nonischemic cardiomyopathy.
Ronald M Witteles, Khun Visith Keu, Andrew Quon, Homa Tavana, Michael B Fowler

J Card Fail· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy-associated cardiotoxicity: how often does it really occur and how can it be prevented?
Ronald M Witteles, Michael B Fowler, Melinda L Telli

Heart Fail Clin· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dyssynchrony Assessment with Tissue Doppler Imaging and Regional Volumetric Analysis by 3D Echocardiography Do Not Predict Long-Term Response to Cardiac Resynchronization Therapy.
Suman S Kuppahally, Michael B Fowler, Randall Vagelos, Paul Wang, Amin Al-Ahmad

Cardiol Res Pract· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subclinical hypothyroidism. Risk factor for heart disease for over 40 years.
Richard A Savage, Samuel Savage, Helen Platts, Amanda Platts, Suzanne Savage, Michael B Fowler, Guy Fowler

BMJ· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement precision in the optimization of cardiac resynchronization therapy.
Robert G Turcott, Ronald M Witteles, Paul J Wang, Randall H Vagelos, Michael B Fowler

Circ Heart Fail· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rosiglitazone increases myocardial glucose metabolism in insulin-resistant cardiomyopathy.
David P Kao, Ronald M Witteles, Andrew Quon, Joseph C Wu, Sanjiv Sam Gambhir, Michael B Fowler

J Am Coll Cardiol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Worsening of left ventricular end-systolic volume and mitral regurgitation without increase in left ventricular dyssynchrony on acute interruption of cardiac resynchronization therapy.
Suman S Kuppahally, Michael B Fowler, Randall Vagelos, Paul Wang, Amin Al-Ahmad

Echocardiography· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypertension, heart failure, and beta-adrenergic blocking drugs.
Michael B Fowler

J Am Coll Cardiol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options.
Ronald M Witteles, Michael B Fowler

J Am Coll Cardiol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical trial.
Ronald M Witteles, David Kao, Dianne Christopherson, Kelly Matsuda, Randall H Vagelos, Michael B Fowler

J Am Coll Cardiol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why do we need to prevent right ventricular pacing?
Angela Tsiperfal, Kimberly Scheibly, Michael B Fowler, Cara Chao

Prog Cardiovasc Nurs· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beta-blocker dosing in community-based treatment of heart failure.
Michael B Fowler, Sandra R Lottes, Jeanenne J Nelson, Mary Ann Lukas, Edward M Gilbert

Am Heart J· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practice.
Barry M Massie, Jeanenne J Nelson, Mary Ann Lukas, Barry Greenberg, Michael B Fowler

Am J Cardiol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability, safety, and efficacy of beta-blockade in black patients with heart failure in the community setting: insights from a large prospective beta-blocker registry.
William T Abraham, Barry M Massie, Mary Ann Lukas, Sandra R Lottes, Jeanenne J Nelson, Michael B Fowler

Congest Heart Fail· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heart failure in community practice: relationship to age and sex in a beta-blocker registry.
Joseph A Franciosa, Jeanenne J Nelson, Mary Ann Lukas, Sandra R Lottes, Barry M Massie, Michael B Fowler

Congest Heart Fail· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of clinical outcomes in patients given carvedilol for heart failure.
Barry Greenberg, Sandra R Lottes, Jeanenne J Nelson, Mary Ann Lukas, Michael B Fowler

Am J Cardiol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging therapies for the management of decompensated heart failure: from bench to bedside.
Emil M deGoma, Randall H Vagelos, Michael B Fowler, Euan A Ashley

J Am Coll Cardiol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of carvedilol on mortality risk in heart failure patients with diabetes: results of a meta-analysis.
David S H Bell, Mary Ann Lukas, Frederick K Holdbrook, Michael B Fowler

Curr Med Res Opin· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are beta-blockers needed in patients receiving spironolactone for severe chronic heart failure? An analysis of the COPERNICUS study.
Henry Krum, Paul Mohacsi, Hugo A Katus, Michael Tendera, Jean-Lucien Rouleau, Michael B Fowler

Am Heart J· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiomyopathy of insulin resistance.
Ronald M Witteles, Michael B Fowler

Heart Fail Clin· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B-type natriuretic peptide is effective therapy before care.
Ronald Witteles, Kelly Matsuda, Michael B Fowler

Ann Intern Med· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of angiotensin-converting enzyme gene polymorphism on neurohormonal responses to high- versus low-dose enalapril in advanced heart failure.
W H Wilson Tang, Randall H Vagelos, Yin-Gail Yee, Michael B Fowler

Am Heart J· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Care management for low-risk patients with heart failure: a randomized, controlled trial.
Robert Frank DeBusk, Nancy Houston Miller, Kathleen Marie Parker, Albert Bandura, Helena Chmura Kraemer, Michael Bruce Fowler

Ann Intern Med· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis